In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates;Yenidoganlardan izole edilen Malassezia suşlarιnιn ketokonazol, itrakonazol ve terbinafine in vitro duyarlιlιǧι

Mikrobiyoloji Bulteni

Volumn 39, Issue 3, 2005, Pages 301-308

  Sancak, Banu ^a   Ayhan, Meltem ^a   Karaduman, Ayşen ^a   Arikan, Sevtap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antifungal susceptibility; Malassezia species

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; KETOCONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ARTICLE; CHEEK; DERMATOMYCOSIS; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MALASSEZIA; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; SCALP;

ANTIFUNGAL AGENTS; CHEEK; DERMATOMYCOSES; HUMANS; INFANT, NEWBORN; ITRACONAZOLE; KETOCONAZOLE; MALASSEZIA; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; SCALP;

EID: 33846430075     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Gueho E, Boekhout T, Ashbee HR, Guillot J, van Belkum A, Faergemann J: The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol 1998, 36 (Suppl 1): 220-229.
2. Bernier V, Weill FX, Hirigoyen V, et al: Skin colonization of Malassezia species in neonates. Arch Dermatol 2002, 138: 215-218.
3. Erchiga VC, Florencio VD: Malassezia species in skin diseases. Curr Opin Infect Dis 2002, 15: 133-142.
4. Guillot J, Gueho E: The diversity of Malassezia yeast confirmed by rRNA sequence and nuclear DNA comparisons. Antonie van Leewenhoek 1996, 67: 297-314.
5. Gueho E, Midgley G, Guillot J: The genus Malassezia with description of four new species. Antonie van Leewenhoek 1996, 69: 337-355.
6. Guillot J, Gueho E, Lesourd M, et al: Identification of Malassezia species. J Mycol Med 1996, 6: 103-110.
7. Sugita T, Takashima M, Shinoda T, et al: New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J Clin Microbiol 2002, 40: 1363-1367.
8. Sugita T, Takashima M, Kodama M, et al: Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol 2003, 41: 4695-4699.
9. Sugita T, Tajima M, Takashima M, et al: A new yeast, M.yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol Immunol 2004, 48: 579-583.
10. Uchida K, Nishiyama Y, Tanaka T, Yamaguchi H: In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Int J Antimicrob Agents 2003, 21: 234-238.
11. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC: In vitro susceptibility of the seven Malassezia species to ketokonazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000, 142: 758-765.
12. Schmidt A, Rühl-Hörster B: In vitro susceptibilities of Malassezia furfur against azole compounds. Mycoses 1996, 39: 309-312.
13. Garau M, Pereino Jr M, del Palacio A: In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrobial Agents Chemother 2003, 47: 2342-2344.
14. Nakamura A, Kano A, Murai T, Watabane S, Hasegawa A: Susceptibility testing of Malassezia species using the urea broth microdilution method. Antimicrob Agents Chemother 2000, 44: 2185-2186.
15. Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G: Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to a new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 2004, 42: 3589-3593.
16. Nakabayashi A, Sei Y, Guillot U: Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000, 38: 337-341.
17. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard, NCCLS Document M27-A2. 2002, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. Sancak B, Rex JH, Chen E, Marr K: Comparison of PCR- and Hinfl restriction endonuclease-based methods for typing of Candida krusei isolates. J Clin Microbiol 2004, 42: 5889-5891.
19. Pizzo G, Giammanco GM, Pecorella S, Campisi G, Mammina C, D'Angelo M: Biotypes and randomly amplified polymorphic DNA (RAPD) profiles of subgingival Candida albicans isolates in HIV infection. New Microbiol 2005, 28: 75-82.